These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34572491)

  • 1. Therapeutic Potential of Curcumin as an Antimycobacterial Agent.
    Barua N; Buragohain AK
    Biomolecules; 2021 Aug; 11(9):. PubMed ID: 34572491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoxazole analogs of curcuminoids with highly potent multidrug-resistant antimycobacterial activity.
    Changtam C; Hongmanee P; Suksamrarn A
    Eur J Med Chem; 2010 Oct; 45(10):4446-57. PubMed ID: 20691508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current prospects of synthetic curcumin analogs and chalcone derivatives against mycobacterium tuberculosis.
    Bukhari SN; Franzblau SG; Jantan I; Jasamai M
    Med Chem; 2013 Nov; 9(7):897-903. PubMed ID: 23305394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prospects for development of new antituberculous drugs].
    Tomioka H
    Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinolidene based monocarbonyl curcumin analogues as promising antimycobacterial agents: Synthesis and molecular docking study.
    Subhedar DD; Shaikh MH; Nawale L; Sarkar D; Khedkar VM; Shingate BB
    Bioorg Med Chem Lett; 2017 Feb; 27(4):922-928. PubMed ID: 28110868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demethoxycurcumin and its semisynthetic analogues as antitubercular agents.
    Agrawal DK; Saikia D; Tiwari R; Ojha S; Shanker K; Kumar JK; Gupta AK; Tandon S; Negi AS; Khanuja SP
    Planta Med; 2008 Dec; 74(15):1828-31. PubMed ID: 18991209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemistry of curcumin: from extraction to therapeutic agent.
    Priyadarsini KI
    Molecules; 2014 Dec; 19(12):20091-112. PubMed ID: 25470276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological evaluation of novel curcumin-pyrazole-mannich derivative active against drug-resistant Mycobacterium tuberculosis.
    Singh AK; Yadav P; Karaulia P; Singh VK; Gupta P; Puttrevu SK; Chauhan S; Bhatta RS; Tadigoppula N; Gupta UD; Chopra S; Dasgupta A
    Future Microbiol; 2017 Nov; 12():1349-1362. PubMed ID: 29035081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and antimycobacterial activity of thiazolidine-2,4-dione-based thiosemicarbazone derivatives.
    Trotsko N; Golus J; Kazimierczak P; Paneth A; Przekora A; Ginalska G; Wujec M
    Bioorg Chem; 2020 Apr; 97():103676. PubMed ID: 32097795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Curcumin in Experimental Pulmonary Tuberculosis: Antimycobacterial Activity in the Lungs and Anti-Inflammatory Effect in the Brain.
    Lara-Espinosa JV; Arce-Aceves MF; López-Torres MO; Lozano-Ordaz V; Mata-Espinosa D; Barrios-Payán J; Silva-Islas CA; Maldonado PD; Marquina-Castillo B; Hernández-Pando R
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Traditional Uses, Therapeutic Effects and Recent Advances of Curcumin: A Mini-Review.
    Slika L; Patra D
    Mini Rev Med Chem; 2020; 20(12):1072-1082. PubMed ID: 32286941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin enhances human macrophage control of Mycobacterium tuberculosis infection.
    Bai X; Oberley-Deegan RE; Bai A; Ovrutsky AR; Kinney WH; Weaver M; Zhang G; Honda JR; Chan ED
    Respirology; 2016 Jul; 21(5):951-7. PubMed ID: 27012592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and antimycobacterial evaluation of novel adamantane and adamantanol analogues effective against drug-resistant tuberculosis.
    Alsayed SSR; Lun S; Payne A; Bishai WR; Gunosewoyo H
    Bioorg Chem; 2021 Jan; 106():104486. PubMed ID: 33276981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New potential drug leads against MDR-MTB: A short review.
    Gatadi S; Nanduri S
    Bioorg Chem; 2020 Jan; 95():103534. PubMed ID: 31884135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation of therapeutic potential of curcumin using nanotechnology: current perspectives.
    Sivasami P; Hemalatha T
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):1004-1015. PubMed ID: 29490502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural antimicrobial peptides against Mycobacterium tuberculosis.
    Abedinzadeh M; Gaeini M; Sardari S
    J Antimicrob Chemother; 2015 May; 70(5):1285-9. PubMed ID: 25681127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.